FDA approves AbbVie's Mavyret for acute hepatitis C, expanding its use to patients 3 and older with or without cirrhosis ...

The charts of all patients with HCV infection were reviewed in detail. Interviews were conducted to obtain further information about prior medical interventions, prior hepatitis infections ...

Private hospitals in Tamil Nadu face Hepatitis B vaccine shortage, impacting vaccination of high-risk adults and healthcare ...

Mavyret marks the first and only direct-acting antiviral approved to treat both acute and chronic hepatitis C virus ...

Competing hepatitis C combination drugs from AbbVie and Gilead are now approved in the EU, as the companies aim to treat patients who cannot be cured with established regimens. AbbVie’s Maviret ...

Dozens of people were struck down during a hepatitis outbreak which has now been linked to a mystery supermarket item after ...

The U.S. Food and Drug Administration (FDA) approved a label expansion for AbbVie Inc’s (NYSE:ABBV) Mavyret ...

Three of the 16 patients were started on MMF for reasons other than AIH. AI: Autoimmune; AIH: Autoimmune hepatitis; AST: Aspartate aminotransferase; AZA: Azathioprine; MMF: Mycophenolate mofetil ...

Further, the two samples that they missed were acute-phase sera, and subsequent samples from these same patients proved to be positive for what Chiron now called the hepatitis C virus. Michael ...

Kathy Seward MacKay lost her husband in 1997 because of tainted blood-clotting products. She’s worried about history ...

Public Health Scotland is taking the lead in the investigation alongside officials with the UK Health Security Agency.